Paul Ian Cross - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Paul Ian Cross's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Paul Ian Cross
Verified
Science Writer, Author, and Educator, Freelance
London
Beats
There is nothing I’m not willing to cover, as long as it serves a public good.
Content
By Paul Ian Cross| Medical News Today Verified Share on PinterestAccording to a new study, a once-weekly dose of tirzepatide can lead to significant, sustained weight loss for up to 3 years in adults with overweight or obesity who do not have diabetes. The findings build on earlier results from the SURMOUNT-1 trial and suggest that treatment responses may vary based on factors such as sex and the presence of obesity-related conditions. Researchers also identified patterns in how participants lost weight over time.
By Paul Ian Cross| Medical News Today Verified Share on PinterestGLP-1 drugs have helped people successfully achieve and maintain weight loss; however, losing muscle has been a significant concern. New research suggests that weight loss treatments using GLP-1 and dual GLP-1/GIP receptor agonists can lead to significant fat loss while still maintaining lean muscle mass. The study found that strength training and enough protein were key to keeping muscle while losing weight, as well as getting guidance from an obesity medicine specialist.
By Paul Ian Cross| Medical News Today Verified Share on PinterestAccording to a new study, a once-weekly dose of tirzepatide can lead to significant, sustained weight loss for up to 3 years in adults with overweight or obesity who do not have diabetes. The findings build on earlier results from the SURMOUNT-1 trial and suggest that treatment responses may vary based on factors such as sex and the presence of obesity-related conditions. Researchers also identified patterns in how participants lost weight over time.
Company Info
Freelance
Freelancer.com is the largest freelancing and crowdsourcing marketplace in the world, connecting over 81 million employers and freelancers across more than 247 countries. Founded in 2009 and based in Sydney, Australia, the platform allows employers to post jobs while freelancers can bid on these projects. It is publicly traded on the Australian Securities Exchange under the ticker ASX:FLN. The platform supports a variety of work categories, including software development, writing, design, and marketing. Freelancer.com also offers contests for creative work, where employers can award prize money to winning entries. Users can choose from different membership plans, including free and paid subscriptions, which provide various benefits. The mobile app enhances project management and communication for users on the go. With a diverse customer base that includes individuals, small businesses, and large enterprises, Freelancer.com plays a significant role in the global online economy.
De Pere, Wisconsin, United States